Literature DB >> 15745227

Biocompatibility of microparticles into soft tissue fillers.

Klaus Laeschke1.   

Abstract

The increasing need for long-lasting injectable soft tissue fillers for the treatment of wrinkles and folds requires a critical discussion of the biocompatibility on a scientific background. Since biological fillers made of collagen and hyaluronic acid will be resorbed over time, copolymer biomaterials with microparticles have been developed in recent years. The microparticles followed special and essential demands because of the interaction with the tissue. In search of an ideal soft tissue filler substance, a variety of biomaterials with microparticles suspended have been created for injecting into dermal defects, into the urethra of patients with urinary incontinence, and in patients with vocal cord insufficiency. The particles differ in chemical composition, surface structure, surface charge, and particle size and evoke different host reactions, accordingly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15745227     DOI: 10.1016/j.sder.2004.09.005

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  7 in total

1.  The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.

Authors:  John K Jackson; Jinying Zhao; Wesley Wong; Helen M Burt
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

2.  Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine.

Authors:  Francisco de Melo; Joanna Marijnissen-Hofsté
Journal:  Dermatol Ther (Heidelb)       Date:  2012-09-28

3.  Applicability of a newly developed bioassay for determining bioactivity of anti-inflammatory compounds in release studies--celecoxib and triamcinolone acetonide released from novel PLGA-based microspheres.

Authors:  Hsiao-yin Yang; Maarten van Dijk; Ruud Licht; Michiel Beekhuizen; Mattie van Rijen; Martina Källrot Janstål; F Cumhur Öner; Wouter J A Dhert; Detlef Schumann; Laura B Creemers
Journal:  Pharm Res       Date:  2014-08-28       Impact factor: 4.200

Review 4.  Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®).

Authors:  Francisco de Melo; Pierre Nicolau; Luca Piovano; Shang-Li Lin; Tiago Baptista-Fernandes; Martyn I King; Alessandra Camporese; Kyungkook Hong; Maria M Khattar; Marie-Odile Christen
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-08

Review 5.  Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics.

Authors:  Marie-Odile Christen; Franco Vercesi
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-01-20

6.  Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial.

Authors:  Marion Michaela Moers-Carpi; Sally Sherwood
Journal:  Dermatol Surg       Date:  2013-01-25       Impact factor: 3.398

7.  An in vitro and in vivo study on the properties of hollow polycaprolactone cell-delivery particles.

Authors:  Barend Andre Stander; Fiona A van Vollenstee; Karlien Kallmeyer; Marnie Potgieter; Annie Joubert; Andri Swanepoel; Lara Kotze; Sean Moolman; Michael S Pepper
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.